The Society of Surgical Oncology, inc.
The American Society of Breast Surgeons.
Annals of Surgical Oncology

Log in | Register

Clinical Outcomes of Taiwanese Patients with cT4 Oral Cavity Squamous Cell Carcinoma: Toward the Identification of the Optimal Initial Treatment Approach for cT4b Patients

Chun-Ta Liao MD, Yu-Wen Wen PhD, Shu Ru Lee PhD, Tsang-Wu Liu MD, Sen-Tien Tsai MD, Ming-Hsui Tsai MD, Jin-Ching Lin MD, Pei-Jen Lou MD, PhD, Pen-Yuan Chu MD, Yi-Shing Leu MD, Kuo-Yang Tsai MD, Shyuang-Der Terng MD, Tsung-Ming Chen MD, Cheng-Hsu Wang MD, Chih-Yen Chien MD, Wen-Cheng Chen MD, Li-Yu Lee MD, Chien-Yu Lin MD, PhD, Hung-Ming Wang MD, Shu-Hang Ng MD, Chih-Hung Lin MD, Tuan-Jen Fang MD,
Head and Neck Oncology
Volume 24, Issue 3 / March , 2017

Abstract

Background

The National Comprehensive Cancer Network guidelines recommend that patients with oral cavity squamous cell carcinoma (OSCC) and cT4b disease should be either included in clinical trials or treated with a nonsurgical approach. However, surgery may be feasible in selected patients with adequate safety margins. Using the nationwide Taiwanese Cancer Registry Database, we examined the prognosis of cT4b OSCC patients in relation to their treatment approach.

Methods

Of the 18,910 patients with previously untreated first primary OSCC identified between 2004 and 2010, 492 (2.6 %) had cT4b tumors. Of them, 327 (66 %) received initial treatment with surgery, whereas 165 (34 %) were initially treated with a nonsurgical approach. Of the latter group, 78 patients subsequently underwent surgery. A 5-year disease-specific survival (DSS) ≥45 % was considered as a favorable outcome.

Results

Better 5-year DSS and overall survival (OS) rates were observed in cT4b patients initially treated with surgery (vs. nonsurgery; DSS, 51 vs. 38 %; OS, 43 vs. 27 %, respectively, p < 0.001). Of the participants initially treated with surgery, patients with cN0–2 disease had better 5-year survival rates (DSS: cN0, 59 %; cN1, 53 %; cN2, 46 %; OS: cN0, 49 %; cN1, 50 %; cN2, 37 %) than those with cN3 disease (DSS: 0 %; OS: 0 %). Among cT4b patients who initially received a nonsurgical treatment, subjects who subsequently underwent surgery showed better outcomes.

Conclusions

Primary surgery is performed in approximately two-thirds of cT4b OSCC patients, with cN0–2 cases showing a good prognosis. Patients who initially received a nonsurgical approach can subsequently be treated with surgery and achieve favorable outcomes.

Add a comment



0 comment(s)